ASMB Assembly Biosciences Inc

Price (delayed)

$3.98

Market cap

$159.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.68

Enterprise value

$90.15M

Sector: Healthcare
Industry: Biotechnology

Highlights

ASMB's quick ratio has surged by 67% since the previous quarter and by 24% year-on-year
ASMB's EPS has surged by 51% year-on-year and by 4% since the previous quarter
ASMB's gross profit is down by 5% QoQ
Assembly Biosciences's revenue has decreased by 5% QoQ

Key stats

What are the main financial stats of ASMB
Market
Shares outstanding
40.16M
Market cap
$159.83M
Enterprise value
$90.15M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.62
Price to sales (P/S)
2.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.2
Earnings
Revenue
$75.02M
EBIT
-$62.7M
EBITDA
-$62.01M
Free cash flow
-$73.71M
Per share
EPS
-$1.68
Free cash flow per share
-$1.86
Book value per share
$6.46
Revenue per share
$1.89
TBVPS
$5.98
Balance sheet
Total assets
$278.9M
Total liabilities
$31.66M
Debt
$8.58M
Equity
$247.24M
Working capital
$207.14M
Liquidity
Debt to equity
0.03
Current ratio
15.29
Quick ratio
14.84
Net debt/EBITDA
1.12
Margins
EBITDA margin
-82.7%
Gross margin
100%
Net margin
-83.6%
Operating margin
-85.8%
Efficiency
Return on assets
-21.6%
Return on equity
-24.5%
Return on invested capital
-37.3%
Return on capital employed
-23.7%
Return on sales
-83.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ASMB stock price

How has the Assembly Biosciences stock price performed over time
Intraday
0.51%
1 week
2.05%
1 month
-7.01%
1 year
-81.07%
YTD
-34.21%
QTD
-13.48%

Financial performance

How have Assembly Biosciences's revenue and profit performed over time
Revenue
$75.02M
Gross profit
$75.02M
Operating income
-$64.34M
Net income
-$62.7M
Gross margin
100%
Net margin
-83.6%
ASMB's operating margin has soared by 86% year-on-year but it is down by 4.8% since the previous quarter
The company's net margin has surged by 86% YoY but it fell by 6% QoQ
Assembly Biosciences's operating income has increased by 37% YoY
Assembly Biosciences's net income has increased by 36% YoY

Growth

What is Assembly Biosciences's growth rate over time

Valuation

What is Assembly Biosciences stock price valuation
P/E
N/A
P/B
0.62
P/S
2.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.2
ASMB's EPS has surged by 51% year-on-year and by 4% since the previous quarter
The price to book (P/B) is 85% lower than the 5-year quarterly average of 4.0 and 61% lower than the last 4 quarters average of 1.6
The equity has increased by 2.8% from the previous quarter
ASMB's price to sales (P/S) is 97% lower than its 5-year quarterly average of 80.6 and 70% lower than its last 4 quarters average of 7.0
Assembly Biosciences's revenue has decreased by 5% QoQ

Efficiency

How efficient is Assembly Biosciences business performance
ASMB's return on sales has surged by 86% year-on-year but it is down by 6% since the previous quarter
The return on equity has grown by 46% year-on-year
The company's return on assets rose by 38% YoY but it fell by 3.8% QoQ
The ROIC has increased by 27% YoY but it has decreased by 11% from the previous quarter

Dividends

What is ASMB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASMB.

Financial health

How did Assembly Biosciences financials performed over time
ASMB's quick ratio has surged by 67% since the previous quarter and by 24% year-on-year
Assembly Biosciences's current ratio has surged by 66% QoQ and by 26% YoY
The company's debt is 97% lower than its equity
The debt to equity has contracted by 40% YoY and by 25% from the previous quarter
The company's debt fell by 27% YoY and by 15% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.